Related Experiment Video
Updated: Oct 23, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral Regurgitation Following Acute Myocardial Infarction Treated by Percutaneous Coronary Intervention-Prevalence,
Harish Sharma1, Ashwin Radhakrishnan1, Peter Nightingale2
1Institute of Cardiovascular Sciences, University of Birmingham, Birmingham, United Kingdom; Department of Cardiology, University Hospitals Birmingham, Birmingham, United Kingdom.
Abstract:
Mitral regurgitation (MR) following acute myocardial infarction (AMI) worsens prognosis and reports of prevalence vary significantly. The objective was to determine prevalence, risk factors, and outcomes related to MR following AMI. We identified 1000 consecutive patients admitted with AMI in 2016/17 treated by percutaneous coronary intervention with pre-discharge transthoracic echocardiography. MR was observed in 294 of 1000 (29%), graded as mild (n = 224 [76%]), moderate (n = 61 [21%]) and severe (n = 9 [3%]). Compared with patients without MR, patients with MR were older (70 ± 12 vs 63 ± 13 years; p <0.001), with worse left ventricular ejection fraction (LVEF) (52 ± 15% vs 55 ± 11%; p <0.001) and creatinine clearance (69 ± 33 ml/min vs 90 ± 39 ml/min; p <0.001). They also had higher rates of hypertension (64% vs 55%; p = 0.012), heart failure (3.4% vs 1.1%; p = 0.014), previous MI (28% vs 20%; p = 0.005) and severe flow-limitation in the circumflex (50% vs 33%; p <0.001) or right coronary artery (51% vs 42%; p = 0.014). Prevalence and severity of MR were unaffected by AMI subtype. Revascularization later than 72 hours from symptom-onset was associated with increased likelihood of MR (33% vs 25%; p = 0.036) in patients with non-ST elevation myocardial infarction (NSTEMI). After a mean of 3.2 years, 56 of 288 (19%) patients with untreated MR died. Age and LVEF independently predicted mortality. The presence of even mild MR was associated with increased mortality (p = 0.029), despite accounting for confounders. In conclusion, MR is observed in over one-quarter of patients after AMI and associated with lower survival, even when mild. Prevalence and severity are independent of MI subtype, but MR was more common with delayed revascularization following NSTEMI.
Insights
Mitral regurgitation (MR) after acute myocardial infarction (AMI) affects over a quarter of patients and is linked to worse survival, even in mild cases. Risk factors include older age and reduced left ventricular ejection fraction.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Echocardiography
Background:
- Mitral regurgitation (MR) following acute myocardial infarction (AMI) is a known complication with significant prognostic implications.
- Existing data on the prevalence and impact of MR post-AMI are varied, necessitating further investigation into risk factors and outcomes.
Purpose of the Study:
- To determine the prevalence of mitral regurgitation in patients following acute myocardial infarction.
- To identify risk factors associated with the development of MR post-AMI.
- To evaluate the impact of MR on patient outcomes and mortality.
Main Methods:
- A cohort of 1000 consecutive patients admitted with AMI between 2016-2017 were analyzed.
- Transthoracic echocardiography was performed pre-discharge to assess for MR.
- Patient demographics, clinical history, AMI characteristics, treatment details, and long-term mortality data were collected and analyzed.
Main Results:
- Mitral regurgitation was present in 29% of patients (294/1000), predominantly mild (76%).
- Patients with MR were older, had worse left ventricular ejection fraction (LVEF), and reduced creatinine clearance.
- Higher rates of hypertension, heart failure, previous MI, and severe coronary artery disease were observed in patients with MR. Delayed revascularization (>72 hours) was associated with increased MR likelihood in NSTEMI patients. Even mild MR was linked to increased mortality over a mean follow-up of 3.2 years.
Conclusions:
- Mitral regurgitation is a common complication after AMI, affecting over a quarter of patients.
- The presence of MR, even when mild, is independently associated with increased mortality post-AMI.
- Risk factors include older age, reduced LVEF, and delayed revascularization in NSTEMI, highlighting the need for early detection and management.
More Related Videos
07:42An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
Published on: May 19, 2020
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Related Concept Videos
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Valve Prolapse I: Introduction